Beam Therapeutics Inc. Retained Earnings
Beam Therapeutics Inc. (BEAM) had Retained Earnings of -$1.86 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-04
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.86B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.74B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.64B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.89B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$1.86B 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$1.74B 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$1.64B 10-Q · filed 2026-08-04 |
| 2025-09-30 | -$1.89B 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$1.78B 10-Q · filed 2025-08-05 |
| 2025-03-31 | -$1.68B 10-Q · filed 2025-05-06 |
| 2024-12-31 | -$1.57B 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.48B 10-Q · filed 2024-11-05 |
| 2024-06-30 | -$1.38B 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$1.29B 10-Q · filed 2024-05-07 |
| 2023-12-31 | -$1.19B 10-K · filed 2025-02-25 |
| 2023-09-30 | -$1.33B 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$1.24B 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$1.15B 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$1.06B 10-K · filed 2024-02-27 |
| 2022-09-30 | -$1.02B 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$909.44M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$837.49M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$768.27M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$703.57M 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$675.45M 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$599.20M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$397.64M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$302.17M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$267.72M 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$233.50M 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$203.04M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |